Volume | 55,422 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 0.615 | Mínimo Máximo |
|||||
Minimo del Dia | 0.5801 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
VBI Vaccines Inc | VBIV | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.6075 | 0.5801 | 0.615 | 0.5951 | 0.61 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
184 | 55,422 | US$ 0.6021588 | US$ 33,373 | - | 0.45 - 3.47 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
17:03:41 | 39 | US$ 0.6218 | USD |
Información Financiera VBI Vaccines Inc VBIV
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
14.21M | 23.69M | - | 8.68M | -93.84M | -3.96 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre VBI Vaccines Inc VBIV
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
29/5/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
29/5/2024 | 07:00 | Business Wire | VBI Vaccines Announces New Tumor Response Data from Ongoing.. |
24/5/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
22/5/2024 | 07:00 | Business Wire | VBI Vaccines Announces Poster Presentation at 2024 ASCO.. |
15/5/2024 | 15:18 | Edgar (US Regulatory) | Form 8-K - Current report |
15/5/2024 | 15:00 | Business Wire | VBI Vaccines Reports First Quarter 2024 Financial Results |
16/4/2024 | 07:00 | Business Wire | VBI Vaccines Reports Full Year 2023 Financial Results |
11/4/2024 | 15:05 | Business Wire | VBI Vaccines Announces Closing of $2 Million Registered.. |
09/4/2024 | 13:45 | Business Wire | VBI Vaccines Announces $2 Million Registered Direct Offering.. |
03/4/2024 | 07:00 | Business Wire | VBI Vaccines Presents Encouraging Early Tumor Response Data.. |
02/4/2024 | 07:00 | Business Wire | VBI Vaccines Announces Expanded Strategic Partnership with.. |
14/2/2024 | 07:34 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos VBIV
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.65 | 0.66255 | 0.56 | 0.6010581 | 123,918 | -0.0549 | -8.45% |
1 Month | 0.623 | 0.67 | 0.56 | 0.6251856 | 109,602 | -0.0279 | -4.48% |
3 Months | 0.6101 | 1.35 | 0.531 | 0.6725002 | 454,685 | -0.015 | -2.46% |
6 Months | 0.64 | 1.35 | 0.522 | 0.6584349 | 278,417 | -0.0449 | -7.02% |
1 Year | 2.84 | 3.47 | 0.45 | 1.61 | 521,740 | -2.24 | -79.05% |
3 Years | 100.50 | 129.30 | 0.45 | 51.92 | 1,489,771 | -99.90 | -99.41% |
5 Years | 53.10 | 217.20 | 0.45 | 74.18 | 3,539,252 | -52.50 | -98.88% |